Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization
机构:[1]Department of Liver Disease and DigestiveInterventional Radiology, Xijing Hospital of Digestive Diseases, ForthMilitary Medical University, Xi’an[2]Department of Minimally InvasiveInternational Therapy, The Third Affiliated Hospital of KunmingUniversity, Tumor Hospital of Yunnan Province, Kunming[3]Departmentof Hepatobiliary and Pancreatic Interventional Center, The First AffiliatedHospital, School of Medicine of Zhejiang University, Hangzhou[4]Department of Interventional Radiology, Henan Cancer Hospital, TheAffiliated Cancer Hospital of Zhengzhou University, Zhengzhou河南省肿瘤医院[5]Department of Hepatobiliary Surgery, Xinqiao Hospital, Third MilitaryMedical University, Chongqing[6]Department of InterventionalRadiology, Affiliated Hospital of Nantong University, Nantong[7]ClinicalLiver Diseases Research Center, 180th Hospital of People’s LiberationArmy, Quanzhou[8]Department of Interventional Radiology, JiangsuProvincial Cancer Hospital, the Affiliated Cancer Hospital of NanjingMedical University, Nanjing[9]Department of Interventional Radiology,Tangdu Hospital, Forth Military Medical University, Xi’an[10]Departmentof Interventional Radiology, The First Affiliated Hospital of SoochowUniversity, Suzhou[11]Department of Interventional Radiology, ZhejiangProvincial Tumor Hospital, Hangzhou[12]Department of Radiology, TheSouthwest Hospital, Third Military Medical University, Chongqing[13]Department of Interventional Radiology, The First Affiliated Hospital ofFujian Medical University, Fuzhou[14]Department of Oncology, TheSecond Affiliated Hospital of Nanchang University, Nanchang[15]Department of Interventional Radiology and Vascular Surgery, HunanProvincial People’s Hospital, Changsha[16]Department of InterventionalRadiology, The First Affiliated Hospital of Sun Yat-Sen University,Guangzhou[17]Department of Interventional Therapy, ShandongProvincial Tumor Hospital[18]Department of Gastroenterology andHepatology, Shandong Province Hospital Affiliated to ShandongUniversity, Jinan[19]Department of Interventional Radiology, The FirstAffiliated Hospital of Nanjing Medical University, Nanjing[20]Interventional Medical Center, The Affiliated Hospital of QingdaoUniversity, Qingdao[21]Department of Interventional Radiology, TheAffiliated Tumor Hospital of Xinjiang Medical University, Urumqi[22]Department of Interventional Medicine, The First Affiliated Hospital ofLanzhou University, Lanzhou[23]Department of Interventional Radiology,Yantai Yuhuangding Hospital, Yantai[24]Department of Medical Imaging,Nanjing General Hospital of Nanjing Military Command, Nanjing[25]State Key Laboratory of Cancer Biology, Xijing Hospital of DigestiveDiseases, Fourth Military Medical University[26]Department of HealthStatistics, Forth Military Medical University, Xi’an, China
第一作者机构:[1]Department of Liver Disease and DigestiveInterventional Radiology, Xijing Hospital of Digestive Diseases, ForthMilitary Medical University, Xi’an
推荐引用方式(GB/T 7714):
D. Xia,W. Bai,M. Huang,et al.Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization[J].JOURNAL OF HEPATOLOGY.2017,66(1):S15-S15.doi:10.1016/S0168-8278(17)30292-1.
APA:
D. Xia,W. Bai,M. Huang,J. Sun,E. Wang...&G. Han.(2017).Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.JOURNAL OF HEPATOLOGY,66,(1)
MLA:
D. Xia,et al."Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization".JOURNAL OF HEPATOLOGY 66..1(2017):S15-S15